At the BIO Patient Advocacy and Changemakers Event (PACE) in Washington, D.C., NPC President and CEO John O’Brien will join Ben Collins of Biogen and Ashira Vantrees of Aimed Alliance for a panel discussion on “Patient Access in the U.S. and Abroad.” The session, which will take place on Monday, October 27 from 3:30 – 4:15 PM ET, will explore the potential implications of adopting HTA-like controls on U.S. patient access.
Image